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The COVID pandemic of 2020 has emerged as a global threat to patients, health care providers, and to the
global economy. Owing to this particular novel and highly infectious strain of coronavirus, the rapid
community spread and clinical severity of the subsequent respiratory syndrome created a substantial
strain on hospitals and health care systems around the world. The rapid surge of patients presenting over
a small period for emergent clinical care, admission to the hospital, and intensive care units with many
requiring mechanically assisted ventilators for respiratory support demonstrated the potential to over-
whelm health care workers, hospitals, and health care systems. The purpose of this article is to describe
an effective system for redeployment of health care supplies, resources, and personnel to hospitals
within a suburban academic hospital system to optimize the care of COVID patients, while treating or-
thopedic patients in an equally ideal setting to maximize their surgical and clinical care. This article will
provide a particular focus on the current and future role of a specialty hip and knee hospital and its
partnering ambulatory surgery center in the context of an outpatient arthroplasty program.
© 2020 Elsevier Inc. All rights reserved.The COVID pandemic is the result of the spread of the SARS-CoV-
2 virus, which results in severe acute respiratory syndrome and in
the most severe cases, death. Its origin is in Wuhan, People's Re-
public of China, with the first cases reported there in December of
2019 and has rapidly spread worldwide since that time. In March
2020, the World Health Organization declared COVID-19 a world
pandemic and to date, over two million people worldwide have
been infected with the SARS-CoV-2 virus and it will continue to
spread throughout the world over the coming months to years. Its
health and economic consequences have been profound and have
affected nearly all countries across the globe [1].closed potential or pertinent
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s, IN 46037.Owing to emerging information and epidemiologic modeling
leading up to its rapid spread here in the United States, many in-
stitutions were able to prepare and enact a coordinated response in
anticipation of what has been termed the “COVID-19 surge,” and
the anticipated shortage of personal protection equipment (PPE),
intensive care unit beds, and respiratory ventilators. This article
will discuss how a suburban hospital region within a large aca-
demic health systemwas able to group COVID patients in hospitals
with optimal capability and expertise to care for those patients
with severe respiratory illness, while utilizing a smaller
orthopedic-focused hospital, Indiana University Hip and Knee
Center at Saxony Hospital, to treat the urgent orthopedic cases. This
article will discuss the successful resource reallocation methodol-
ogy with a particular emphasis on the outpatient and ambulatory
setting.COVID-19 Surge Anticipation
Indiana University (IU) Health is the largest health system in the
state of Indiana with 2708 total beds and over 118,000 hospital
admissions annually and is partnered with the nation’s largest
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close cooperation with our state government and examination of
available epidemiological models, IU Health determined that a
surge of patients affected by the novel coronavirus would
encounter our health system in late March and within an antici-
pated peak in mid to late April. Our program made the decision to
stop all elective, nonurgent hip and knee arthroplasty surgery on
March 17, 2020, and based on evolving data that became clear, the
ambulatory aspect of patient care also ceased immediately. From a
hip and knee arthroplasty perspective, appropriately triaging pa-
tients based on the extent of their clinical condition and acuity was
paramount.
Concurrently, with the canceling of all elective surgeries and
nonurgent patients in the ambulatory clinic setting, protocols were
rapidly being developed to care for the more urgent needed or-
thopedic hip and knee arthroplasty patients, which included those
with infections, fractures, and periprosthetic hip and knee frac-
tures. The Indiana University Hip and Knee Center at Saxony Hos-
pital is part of a four hospital regional health network called the
Indianapolis Suburban Region (ISR) and the administrative and
clinical leadership immediately developed and enacted a plan to
preserve PPE and hospital resources to support the appropriate
deployment to the frontline caregivers that included emergency
room physicians, pulmonologist, anesthesiologists, and critical care
physicians and teammembers. Simultaneously, PPE and equipment
such as ventilators were moved from our orthopedic-focused
hospital to the two larger hospitals in the ISR where COVID pa-
tients would be treated predominantly.
From an outpatient perspective our ambulatory clinic made a
number of significant changes that optimized patient safety as well
as preservation of personal protective equipment. Patients and staff
members are required to use masks during every patient interac-
tion and patients were seen in person only if the patient’s clinical
condition was deemed urgent. All examination rooms in their en-
tirety were thoroughly cleaned with disinfectant between each and
every patient. In addition, like many other institutions in the United
States and abroad, virtual interaction with existing and potential
patients was initiated using HIPAA compliant software. Virtual
clinic visits were offered to follow-up and new patients, who
consented to that form of clinical interaction.
Unique to the outpatient surgery environment, the ambulatory
surgery center facilities played a significant and vital role in terms
of contributing resources to accommodate the surge of COVID-19
patients. IU Health has a unique and collaborative partnership
with Surgical Care Affiliates (SCA). The partnership between the
two entities encompasses 14 discrete ambulatory surgery centers
(ASCs) whose operations are run by IU Health with administrative
support from SCA. The 14 IU Health ASCs perform approximately
75,000 outpatient surgeries annually, and analogous to the main
hospitals, the ASCs stopped all elective surgeries onMarch 17, 2020.
Supplies and staff from the ASCs were redeployed into the hospitals
to serve vital roles in the continued health care expansion to accept
the medically ill patients within the COVID-19 surge. In fact,
approximately 85% of extra supplies and equipment needed for the
frontline providers in the four ISR hospitals were provided by the
ASCs, clearly demonstrating the critically important role that the
ASCs played and continue to play in the COVID pandemic response.
It is important to recognize the leadership role that ASCs play in the
2020 COVID-19 pandemic. SCA is one of many ambulatory surgery
center entities in the United States who play a vital role in health
care delivery and were vital in rapidly deploying PPE, ventilators,
supplies, and staff to the various hospitals. In our particular health
system, three of the ambulatory surgery centers remained open for
urgent ambulatory surgical care. This further supported the health
care resource conundrum, by performing urgent surgical care forless complex ambulatory procedures in the ASCs which allowed the
more medically complex COVID-19 patients to have access to the
inpatient hospital system. Some guidelines and publications have
been established regarding what constitutes an “urgent” procedure
within and ASC or outpatient setting [2]. It is generally accepted
that an “urgent” procedure is a surgery that would increase the risk
of permanent impairment or pain if not performed in a timely
manner.
The result of this rapid and effective systemwide planning, uti-
lizing ASC resources in close partnership with our health care
system, allowed adequate capacity to handle the COVID-19 surge
without any shortages of ventilators or ICU beds. In addition, our
health system provided the care for approximately 60% of the
COVID-19 patients in the State of Indiana. The social distancing
efforts and state-mandated stay-at-home order was effective in
“flattening” the curve of clinically relevant viral spread within our
state and the subsequent burden placed on our health system
(Fig. 1). As of April 16, 2020, the State of Indiana reported a flat-
tening of the curve with 45% of ICU beds and 76% of ventilators
across the state available. Specifically, the IU Health system data
revealed a general flattening of the overall inpatient census with a
gradually smaller percentage requiring ICU status and/or ventilator
support (Fig. 1). More encouragingly, the daily admissions into the
IU Health system declined over the same period after a peak in late
March (Fig. 2).
Post-COVID-19 or “Reverse Surge”
At the time of this publication, there is much speculation about
what the future of hip and knee arthroplasty outpatient surgery
holds within the United States and abroad. Nonetheless, the sta-
tistical models of viral spread are rapidly evolving and becoming
more accurate as we continue to understand the details of this
novel coronavirus and its clinical sequelae. Our hip and knee
arthroplasty program is diligently developing protocols for keeping
patients and health care workers safe on the point in time that we
resume elective hip and knee arthroplasties. There are multiple
factors that will need to be accounted for and the ASCs will likely
play an expanded role in access to surgical care for patients with
hip and knee arthritis.
First are the protocols that must be developed to safely perform
hip and knee arthroplasty in the COVID-19 era. It is probable that
every patient regardless of symptoms will need to be tested for
COVID-19 before elective surgery within a certain time before
surgery. This will need to be embedded in the perioperative med-
ical pathways which are typical for hip and knee arthroplasty
programs. It is also likely that all the surgical care teams and pro-
viders in the ambulatory surgery centers will need to self-monitor
and document they are afebrile and do not have any COVID-19-type
symptoms at a minimum before caring for the patients for the day
and as rapid testing is further developed and accessible, may need
to be performed on a regular basis to the OR personnel because
asymptomatic shed of the virus can occur with some frequency. As
testing and clinical information become more available and accu-
rate, it is paramount that patient and health care worker safety is
the number one priority. Likely the most important component of
successfully and safely performing elective total hip and knee sur-
gery is accurate and accessible preoperative COVID-19 testing.
It is important to understand that the specific COVID-19 testing
is not a minimal requisite to performing total hip and knee
arthroplasty in patients with the expectations for same day
discharge. Over the past few years, there has been substantial
research that provides guidance on safe patients selection, optimal
pathways and protocols, and the essential elements for successfully
and safely performing hip and knee arthroplasty in the outpatient
Fig. 1. Inpatient and observation COVID-19 census data for a large academic health system over time demonstrating the flattening curve phenomenon.
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avoid the most common pitfalls and barriers to discharge such as
postoperative urinary retention [6]. It is mandatory that surgeons,
institutions, and programs develop and maintain appropriate
outpatient arthroplasty protocols, in addition to the additional
COVID-19 testing [4].
There is a definite trend in United States over the past few years
in performing a greater percentage of total hip and knee arthro-
plasty patients in the outpatient environment with same day
discharge to home. Recent developments include removing total
knee arthroplasty off the inpatient-only list in 2018, followed by
removing total hip arthroplasty off the inpatient-only list and
allowing total knee arthroplasty to be performed in Medicare
beneficiaries in a freestanding ASC January 2020. There have beenFig. 2. COVID-19 inpatient and observation admissions by arrival dates at a large academi
current.substantial advantages purported for performing hip and knee
arthroplasty in the outpatient setting that have included improved
patient satisfaction [7], less complications, and minimizing the
inpatient hospital burden. It has been further shown that outpa-
tient total knee arthroplasty is feasible in the Medicare population
[8]. The latter benefits have the potential to becoming increasingly
important in the post-COVID-19 era. From a health care resource
perspective, the COVID-19 pandemic has highlighted our national
health care infrastructure in some geographies may not have ca-
pacity to handle large numbers of medically ill patients without
compromising the ability to provide elective surgical care, such as
hip and knee arthroplasty. The ASCs can provide a great benefit to
the health care system by expanding their capacity to accept hip
and knee arthroplasty patients who meet medical and surgicalc health system, demonstrating the steady decline of admissions from late May until
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pacity for the larger inpatient hospitals to safely accept and treat
medically ill patients, like those with respiratory illness from
COVID-19. This impact will not only be prevalent in the short term,
but will also be lasting as it has become known that COVID-19 will
continue in our society for the next few years until larger, broad-
based immunity is enacted through a vaccine and consistent
exposure to the virus by the population. ASC infrastructurewill face
a challenge in terms of capacity to handle these larger and more
complex surgical procedures such as hip and knee arthroplasty.
Although COVID-19 has accelerated the push for hip and knee
arthroplasty within the outpatient setting, ASCs have been
addressing the facility limitations over the past few years because
of external forces led by the government and Center for Medicare
and Medicaid Services. Now that Medicare beneficiaries are able to
undergo knee arthroplasty in freestanding ASCs, these facilities
have been attempting to address their subsequent shortcomings
that include limited capacity in terms of available square footage,
inadequate central sterile processing capacity for larger numbers of
trays, and in some cases, lack of qualified staff who are capable of
caring for hip and knee arthroplasty patients. Compared with the
traditional smaller surgeries performed in ASCs, total hip and knee
arthroplasty can be associated with more blood loss, more soft
tissue trauma, and unique perioperative issues in the first few
hours after surgery that may challenge the ASC staff. However, with
proper training, experience, and mentoring from others with
experience discharging hip and knee arthroplasty patients the
same day of surgery, the ASC staff can become proficient and
capable in caring for these patients.
Finally, patient demand will almost certainly fuel an increasing
surgical volume of hip and knee arthroplasty into the ASC facilities.
Although traditionally only about half of patients were aware that
outpatient total joint arthroplasty was an option as reported in one
recent study [9], the increased patient demand in the post-COVID-
19 era will be primarily driven by the lingering fear by patients and
their families that hospitals are the primary societal location of the
highly contagious and potentially lethal SARS-CoV-2 virus. This fear
has spawned from the data (and media coverage) demonstrating
this particular virus is highly contagious and can affect even well-
protected health care workers and can be spread in a high per-
centage of asymptomatic individuals and in some cases, can prove
fatal by mechanisms not currently understood.
Conclusion
In summary, the ambulatory and outpatient setting will not be
exempt from the significant change and paradigm change occurring
as a result of the COVID-19 pandemic. ASCs and hospitals will havea unique set of challenges and also a unique opportunity to be the
beneficiary of an accelerated push for the hip and knee arthroplasty
to be performed in the outpatient setting. Subsequently, there
should be a significant effort and commitment to putting together
pathways, protocols, resources, and facilities that can safely care for
the hip and knee arthroplasty patient with a plan for same day
discharge, to spare and conserve health care resource consumption.
From our own personal experience and implementation of rapid
redeployment of resources, staff, and supplies with a close part-
nership and collaboration with our ASCs, IU Health was able to
successfully treat all of the COVID-19 patients without over-
burdening the system and we anticipate also being able to treat
these patients safely going forward with a renewed emphasis on
early discharge, both from the ambulatory surgery center as well as
from within the hospital itself.Acknowledgment
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